Association between parenteral nutrition containing intravenous lipid emulsions and bloodstream infections in patients with single-lumen central venous access: A secondary analysis of a randomized trial
CONCLUSION: Our data indicates that twice as many primary BSIs in ILE PN patients are due to mucosal barrier injuries than CVADs. It is important to consider the MBI-LCBI classification, as some CLABSI prevention efforts aimed at CVADs for the ILE PN population may be better directed to gastrointestinal tract protection interventions. This article is protected by copyright. All rights reserved.PMID:37288612 | DOI:10.1002/jpen.2530 (Source: JPEN Journal Of Parenteral And Enteral Nutrition)
Source: JPEN Journal Of Parenteral And Enteral Nutrition - June 8, 2023 Category: Nutrition Authors: Nicole C Gavin Emily Larsen Naomi Runnegar Gabor Mihala Samantha Keogh David McMillan Gillian Ray-Barruel Claire M Rickard Source Type: research
Social Determinants of Maintaining Nutrition in Older Adults with Advanced Dementia
AbstractDysphagia is recognised as part of the frailty syndrome, especially for those at the end of life. There is a tension in management between the need to optimize nutrition status as part of the management of oral frailty, and respecting the wishes of patients and/or family members in the form of advance care planning and advance directives regarding to artificial nutrition and hydration. Management will likely be influenced by many social determinants, rather than solely be based on evidence from clinical research. (Source: The Journal of Nutrition, Health and Aging)
Source: The Journal of Nutrition, Health and Aging - June 5, 2023 Category: Nutrition Source Type: research
Y-site injection physical compatibility of remdesivir with select intravenous drugs used in palliative care and for treating coronavirus disease 2019
CONCLUSIONS: The drugs tested in this study show Y-site physical compatibility with remdesivir.PMID:37271548 | DOI:10.1272/jnms.JNMS.2023_90-508 (Source: Journal of Nippon Medical School)
Source: Journal of Nippon Medical School - June 4, 2023 Category: Universities & Medical Training Authors: Masayoshi Kondo Mai Genpei Kei Watanabe Masato Yoshida Naoya Tagui Shouhei Fukao Kazutoshi Sugaya Hisamitsu Takase Source Type: research
Y-site injection physical compatibility of remdesivir with select intravenous drugs used in palliative care and for treating coronavirus disease 2019
CONCLUSIONS: The drugs tested in this study show Y-site physical compatibility with remdesivir.PMID:37271548 | DOI:10.1272/jnms.JNMS.2023_90-508 (Source: Journal of Nippon Medical School)
Source: Journal of Nippon Medical School - June 4, 2023 Category: Universities & Medical Training Authors: Masayoshi Kondo Mai Genpei Kei Watanabe Masato Yoshida Naoya Tagui Shouhei Fukao Kazutoshi Sugaya Hisamitsu Takase Source Type: research
Y-site injection physical compatibility of remdesivir with select intravenous drugs used in palliative care and for treating coronavirus disease 2019
CONCLUSIONS: The drugs tested in this study show Y-site physical compatibility with remdesivir.PMID:37271548 | DOI:10.1272/jnms.JNMS.2023_90-508 (Source: Journal of Nippon Medical School)
Source: Journal of Nippon Medical School - June 4, 2023 Category: Universities & Medical Training Authors: Masayoshi Kondo Mai Genpei Kei Watanabe Masato Yoshida Naoya Tagui Shouhei Fukao Kazutoshi Sugaya Hisamitsu Takase Source Type: research
Peripheral Parenteral Nutrition: An evaluation of its use, safety and cost implications in a tertiary hospital setting.
Malnutrition is a common challenge among hospitalised patients, is associated with poor patient health-related outcomes and places a significant financial burden on the healthcare system. Total parenteral nutrition (TPN) is the primary means for providing nutrition to individuals in whom enteral feeding is not possible but is costly and requires invasive central venous access. Peripheral parenteral nutrition (PPN) provides a suitable option for early nutrition provision in select patients; however, its routine use has been limited by safety and tolerability concerns, with high rates of phlebitis reported in previous studie...
Source: Clinical Nutrition ESPEN - June 4, 2023 Category: Nutrition Authors: Anisah Inayat-Hussain, Heather Falck, Sarah Oorschot, Sherman Picardo, Kenji So Tags: Original article Source Type: research
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring
CONCLUSIONS: Our study highlights the importance of performing follow-up upper and lower gastrointestinal endoscopy in SBS patients treated with teduglutide and the potential need to make changes to the recommendations with respect to treatment initiation and follow-up.PMID:37270288 | DOI:10.1016/j.ajcnut.2023.02.015 (Source: Am J Clin Nutr)
Source: Am J Clin Nutr - June 3, 2023 Category: Nutrition Authors: Brune de Dreuille Dominique Cazals-Hatem Maxime Ronot Nathalie Theou-Anton Sol ène Dermine Johanne Le Beyec-Le Bihan Lore Billiauws Maude Le Gall Andr é Bado Francisca Joly Source Type: research
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome
CONCLUSIONS: Increased intestinal absorption and PN dependency reduction were observed with teduglutide treatment in children with SBS-IF.TRIAL REGISTRATION: ClinicalTrials.gov NCT03562130. https://clinicaltrials.gov/ct2/show/NCT03562130?term=NCT03562130&draw=2&rank=1.PMID:37270289 | DOI:10.1016/j.ajcnut.2023.02.019 (Source: Am J Clin Nutr)
Source: Am J Clin Nutr - June 3, 2023 Category: Nutrition Authors: C écile Lambe C écile Talbotec Nathalie Kapel Laurence Barbot-Trystram S éverine Brabant Elie Abi Nader B énédicte Pigneur Elise Payen Olivier Goulet Source Type: research
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome
CONCLUSIONS: Increased intestinal absorption and PN dependency reduction were observed with teduglutide treatment in children with SBS-IF.TRIAL REGISTRATION: ClinicalTrials.gov NCT03562130. https://clinicaltrials.gov/ct2/show/NCT03562130?term=NCT03562130&draw=2&rank=1.PMID:37270289 | DOI:10.1016/j.ajcnut.2023.02.019 (Source: The American Journal of Clinical Nutrition)
Source: The American Journal of Clinical Nutrition - June 3, 2023 Category: Nutrition Authors: C écile Lambe C écile Talbotec Nathalie Kapel Laurence Barbot-Trystram S éverine Brabant Elie Abi Nader B énédicte Pigneur Elise Payen Olivier Goulet Source Type: research
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring
CONCLUSIONS: Our study highlights the importance of performing follow-up upper and lower gastrointestinal endoscopy in SBS patients treated with teduglutide and the potential need to make changes to the recommendations with respect to treatment initiation and follow-up.PMID:37270288 | DOI:10.1016/j.ajcnut.2023.02.015 (Source: The American Journal of Clinical Nutrition)
Source: The American Journal of Clinical Nutrition - June 3, 2023 Category: Nutrition Authors: Brune de Dreuille Dominique Cazals-Hatem Maxime Ronot Nathalie Theou-Anton Sol ène Dermine Johanne Le Beyec-Le Bihan Lore Billiauws Maude Le Gall Andr é Bado Francisca Joly Source Type: research
High Protein Intake: Effect of Level vs Feeding Site
This article is protected by copyright. All rights reserved.PMID:37269224 | DOI:10.1002/jpen.2529 (Source: JPEN Journal Of Parenteral And Enteral Nutrition)
Source: JPEN Journal Of Parenteral And Enteral Nutrition - June 3, 2023 Category: Nutrition Authors: Bruce R Bistrian Source Type: research
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome
CONCLUSIONS: Increased intestinal absorption and PN dependency reduction were observed with teduglutide treatment in children with SBS-IF.TRIAL REGISTRATION: ClinicalTrials.gov NCT03562130. https://clinicaltrials.gov/ct2/show/NCT03562130?term=NCT03562130&draw=2&rank=1.PMID:37270289 | DOI:10.1016/j.ajcnut.2023.02.019 (Source: Am J Clin Nutr)
Source: Am J Clin Nutr - June 3, 2023 Category: Nutrition Authors: C écile Lambe C écile Talbotec Nathalie Kapel Laurence Barbot-Trystram S éverine Brabant Elie Abi Nader B énédicte Pigneur Elise Payen Olivier Goulet Source Type: research
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring
CONCLUSIONS: Our study highlights the importance of performing follow-up upper and lower gastrointestinal endoscopy in SBS patients treated with teduglutide and the potential need to make changes to the recommendations with respect to treatment initiation and follow-up.PMID:37270288 | DOI:10.1016/j.ajcnut.2023.02.015 (Source: Am J Clin Nutr)
Source: Am J Clin Nutr - June 3, 2023 Category: Nutrition Authors: Brune de Dreuille Dominique Cazals-Hatem Maxime Ronot Nathalie Theou-Anton Sol ène Dermine Johanne Le Beyec-Le Bihan Lore Billiauws Maude Le Gall Andr é Bado Francisca Joly Source Type: research
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring
CONCLUSIONS: Our study highlights the importance of performing follow-up upper and lower gastrointestinal endoscopy in SBS patients treated with teduglutide and the potential need to make changes to the recommendations with respect to treatment initiation and follow-up.PMID:37270288 | DOI:10.1016/j.ajcnut.2023.02.015 (Source: The American Journal of Clinical Nutrition)
Source: The American Journal of Clinical Nutrition - June 3, 2023 Category: Nutrition Authors: Brune de Dreuille Dominique Cazals-Hatem Maxime Ronot Nathalie Theou-Anton Sol ène Dermine Johanne Le Beyec-Le Bihan Lore Billiauws Maude Le Gall Andr é Bado Francisca Joly Source Type: research
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome
CONCLUSIONS: Increased intestinal absorption and PN dependency reduction were observed with teduglutide treatment in children with SBS-IF.TRIAL REGISTRATION: ClinicalTrials.gov NCT03562130. https://clinicaltrials.gov/ct2/show/NCT03562130?term=NCT03562130&draw=2&rank=1.PMID:37270289 | DOI:10.1016/j.ajcnut.2023.02.019 (Source: The American Journal of Clinical Nutrition)
Source: The American Journal of Clinical Nutrition - June 3, 2023 Category: Nutrition Authors: C écile Lambe C écile Talbotec Nathalie Kapel Laurence Barbot-Trystram S éverine Brabant Elie Abi Nader B énédicte Pigneur Elise Payen Olivier Goulet Source Type: research
